Camlin Fine Sciences Ltd Q1 FY2027 Concall Summary

Key Takeaways

• A brutal quarter, but a self-inflicted one: Gross margin collapsed from 45%+ to 4% as raw material costs, freight, and working capital financing all hit at once. Management is confident the worst is behind, with all three verticals guided to improve significantly in Q2.
• Aroma is the swing factor: The first ethyl vanillin campaign ran at only ~25% utilization, burning ₹4–4.5 crore in negative EBITDA. The switch to methyl vanillin, with lower costs and higher margins, is the single biggest lever for the promised recovery.
• Guidance cut, but still ambitious: Full-year EBITDA margin guidance was revised down to 10–12% from prior levels, implying ₹220–230 crore EBITDA on ₹2,200–2,300 crore revenue. That requires a dramatic second-half swing from Q1's ~₹9 crore EBITDA.
• Working capital is quietly eating margins: Dealer and supplier financing embedded 1–1.5% of interest cost into raw material prices, while the Brazil fire forced ~₹8 crore of air-freight losses. A ₹100–150 crore credit line is expected in 1–1.5 months to relieve the squeeze.
• What to watch next quarter: Whether Aroma actually turns EBITDA-positive on the methyl vanillin switch, whether blends margins recover as the Brazil air-freight drag clears, and whether the promised credit line materializes on schedule.

The Margin Collapse: What Actually Happened

• Gross margin fell off a cliff: From 45%+ last quarter to 4% this quarter, driven by three compounding factors: raw material price spikes, freight cost increases, and working capital financing costs embedded in material prices.
• The financing trade-off: Using dealer and supplier financing instead of borrowing meant interest costs were hidden in raw material prices, shaving 1–1.5% off gross margin. Management frames this as a liquidity decision, not a permanent cost structure change.
• Normalized margin lost 4–5%: Management estimates 3–4% of the gross margin loss was geopolitical (raw material and freight), while 1–2% was liquidity-driven. Had the 4% been retained, EBITDA would have been more than 10%.
• Raw material pass-through lag: Blends customers saw only partial pass-through of material cost increases in Q1 due to a one-quarter lag. In Q2, management expects to pass on roughly half of the remaining increase.
• The war premium persists: Raw material prices are expected to stay elevated through Q2 because the conflict keeps prices moving in directions "we don't understand sometimes." Guidance assumes elevated prices for three months, not six or nine.

Santosh Parab: "In other words, the interest which I paid by borrowing, I'm paying it to the cost of raw material. So that 1%, 1.5% has impacted me because of this bit of a working capital need has impacted my gross margin."

Aroma: The First Campaign Was the Hard Part

• Capacity utilization was the core problem: The large ethyl vanillin campaign was run for the first time, and ramp-up was deliberately cautious to ensure quality. Only ~400 tons were produced against 1,500 tons of capacity, leaving fixed costs unabsorbed.
• The EBITDA burn: Aroma lost ₹4–4.5 crore in EBITDA because expenditures were at full capacity while utilization was hardly 25%.
• Ethyl vanillin reached breakeven: Despite the high-cost first run, the company hit breakeven on ethyl vanillin. Management expects the next ethyl run to have margins similar to methyl vanillin once high-cost materials and intermediates are rationalized.
• Customer approval was the win: ~95% of customers approved ethyl vanillin on the first shot, which management frames as validation of the cautious ramp-up strategy.
• The methyl vanillin switch is the catalyst: The 700-ton ethyl campaign completes in August, followed by a two-week shutdown, then methyl vanillin production begins. Methyl vanillin has lower cost and significantly better gross and EBITDA margins.
• Q2 Aroma should turn positive: Management expects positive Aroma EBITDA in Q2 despite similar volumes to Q1, from the switch to methyl vanillin. The EBITDA difference is only ₹4 crores, but the direction matters.
• Q3 is the real test: The main quarter will see 1,000+ tons of production and sale, with Aroma closest to normalized margins because methyl vanillin runs with all raw materials in place.

Nirmal Momaya: "No, I think first is capacity utilization, okay? That's the first thing which is in our hands that we can start increasing the capacity utilization. Of course, there is the question of financing for that, which we are using trade finance now. So it may impact the margin slightly, but at least the capacity utilization goes up and the cost comes down."

Performance Chemicals: The Diphenol Shutdown Drags

• Diphenol plant remains shut: The plant is closed primarily for economic reasons: phenol and other raw material prices are too high to make manufacturing commercially viable. The company is procuring intermediates from China at competitive prices instead.
• The segment went negative: Performance Chemicals posted negative EBITDA in Q1 because of diphenol closure costs and selling catechol at a loss. That catechol sale has now stopped, with all production diverted to internal consumption.
• Internal transfers mask the real picture: Of ₹175 crores in Performance Chemicals revenue, ₹130 crores is internal transfer and only ₹40 crores is external sale. A large part of straights margin is captured under Performance Chemicals via transfer pricing.
• Q2 should flip positive: Management expects Performance Chemicals EBITDA to turn positive next quarter due to the shutdown switching to other products and better resource planning.
• Alternatives being explored: The company is working on alternatives for diphenol plant utilization, with a decision expected in the next few months. By Q3, management will decide either on an alternate use or a shift back to diphenol production if economics improve.

Blends: Brazil Fire and Margin Pressure

• Brazil fire created a one-time hit: The February fire caused stock shortages, forcing the company to air-freight stock at high prices and buy raw material from competitors at higher rates. The Q1 impact was ~₹8 crore negative in blends.
• Brazil margins compressed: Blends margin in Brazil was hardly 20–22% because of the fire-related stock shortage. Sea-shipped material has now landed and is being consumed in Q2, so the drag should correct.
• Mexico and U.S. underperformed: These regions should have delivered 17% margin but did 14% because of lost gross margin from raw material pass-through delays.
• Growth story intact: Management guides minimum 20% growth in blends this year, with budgets targeting 25–30%. The 20% run rate is already in place and expected to be exceeded.
• Q2 margin recovery expected: Blends margin will be better than Q1 as the Brazil negative corrects and certain businesses pass on raw material price increases.

Vanillin: Demand, Pricing, and the Competitive Landscape

• Channel inventory cleared: Vanillin channel stocks are getting cleared out, and the issue is now out of the way. Pre-antidumping duty inventory and Chinese channel stocks in the U.S. are dried out, with no overhang in any country.
• Demand is picking up: Management estimates 3,000–4,000 tons of vanillin demand this year, and the company may not be able to produce that much because of campaign switches.
• FY27 production revised down: Vanillin production is now expected around 3,000 tons, down from 3,600–4,000 guided previously, because of four campaigns and four months of production lost to campaign switches.
• FY28 scale-up planned: Ideally, the company should produce 4,000 tons in eight months of running, with three campaigns instead of four, scaling up to 5,000 tons.
• U.S. and Europe opportunity: There is a gap of 5,000–6,000 tons to be imported in these markets, and the company sees opportunity to participate in that supply.
• The pricing puzzle: Management deflected a question about why vanillin prices aren't rising in the U.S. and Europe despite Chinese import duties, pointing instead to Syensqo's pricing behavior as the market leader.
• Antidumping mechanics: The antidumping duty protects Syensqo, which indirectly sets the price. If Syensqo raises its sale price, the Chinese duty-adjusted price rises too, allowing Chinese competition to re-enter despite the 250% duty.

Santosh Parab: "The antidumping is to protect Solvay. Solvay is indirectly deciding the price, right? If they sell at $18, the Chinese has to bear 250% duty, which comes to $7, $8. And that is how they have kept Chinese out. If they make the sale price to $21, the Chinese price becomes 8%, 8.5%, -- 5%. So, despite 250%, they will start competing."

Balance Sheet, Working Capital, and Capital Allocation

• Debt reduced: Gross debt fell from ~₹670 crore to ₹640 crore, mainly due to prepayments on long-term IFC and EXIM loans for the vanillin plant. No increase in debt during the last three months.
• Working capital elongation: Hormuz Strait and Red Sea issues force shipping around South Africa, increasing working capital needs. Global slowdown also elongated customer recovery by a few days.
• Credit line coming: The company is working on ₹100–150 crores of credit funding, expected in place in the next 1–1.5 months. Management may need ₹100–200 crore plus in credit lines as the year progresses for working capital support on ₹2,400 crore revenue.
• Brazil insurance settled: The company settled the insurance claim for ~₹40 crore with a 20% haircut rather than haggling, because cash was required. The accounting impact is shown under exceptional items.
• Capital raise deferred: No immediate plan for capital infusion. Management will consider market price, interest rate, and rating at the appropriate time, and will inform investors when a final decision is taken.
• CFS Europe liquidation: Already in liquidation, with no more cash burn except small legal costs until the process completes. China liquidation is in process and expected to complete this year, with ~₹1–2 crore expenditure expected this quarter.

Santosh Parab: "It's not the time now that I'm standing on the edge of the hill and I have to jump. There is time still."

Guidance & Commitments

Key Metrics